Clinical trial
Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in…
NCT00101140 · Eastern Cooperative Oncology Group, Other · Withdrawn
Key facts
| NCT number | NCT00101140 |
|---|---|
| Title | Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission |
| Official title | Phase II Study of Haploidentical Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With High-Risk Acute Myeloid Leukemia in First Remission |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adult Acute Erythroid Leukemia, Adult Acute Monoblastic and Acute Monocytic Leukemia, Adult Acute Myeloid Leukemia |
| Intervention type | Drug, Procedure |
| Interventions | anti-thymocyte globulin, fludarabine phosphate, thiotepa, biological therapy, bone marrow ablation with stem cell support, chemotherapy, non-specific immune-modulator therapy, peripheral blood stem cell transplantation, radiation therapy |
| Enrollment | 0 |
| First posted | Jan 10, 2005 |
| Last update posted | Oct 19, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: